Article
Absence of biochemical evidence at an early age delays diagnosis in a patient with a clinically severe peroxisomal biogenesis disorder.
European journal of paediatric neurology : EJPN : official journal of the European Paediatric Neurology Society - 1 Mar 2016
Lüsebrink Natalia, Porto Luciana, Waterham Hans R, Ferdinandusse Sacha, Rosewich Hendrik, Kurlemann Gerd, Kieslich Matthias
Abstract excerpt
Analysis of the plasma levels of very long chain fatty acids (VLCFA) is a primary screening method for peroxisomal disorders and usually identifies severe peroxisomal biogenesis defects reliably. We report a patient presenting with typical facial stigmata, a treatment resistant seizure disorder and polymicrogyria, whose plasma VLCFA levels were within normal limits until the age of 18 months. Only thereafter an...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
